Literature DB >> 11549445

Incorporation of 2'-deoxy-5-(trifluoromethyl)uridine and 5-cyano-2'-deoxyuridine into DNA.

J C Markley1, P Chirakul, D Sologub, S T Sigurdsson.   

Abstract

In an attempt to synthesize DNA containing 2'-deoxy-5-(trifluoromethyl)uridine (1) using previously published protocols, we found that the trifluoromethyl group converted into a cyano group, resulting in DNA containing 5-cyano-2'-deoxyuridine (3). We show that nucleoside 1 can be incorporated into DNA using phosphoramidite 2 in combination with acetyl-protected deoxycytidine and phenoxyacetyl-protected purine phosphoramidites. Replacing thymidine in DNA with 1 caused a slight decrease in DNA duplex stability at pH 6.9.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11549445     DOI: 10.1016/s0960-894x(01)00461-9

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  14 in total

1.  A nonafluoro nucleoside as a sensitive 19f NMR probe of nucleic acid conformation.

Authors:  Nivrutti B Barhate; Rekha N Barhate; Pavol Cekan; Gary Drobny; Snorri Th Sigurdsson
Journal:  Org Lett       Date:  2008-06-06       Impact factor: 6.005

2.  Vibrational stark effect probes for nucleic acids.

Authors:  Lisa N Silverman; Michael E Pitzer; Peter O Ankomah; Steven G Boxer; Edward E Fenlon
Journal:  J Phys Chem B       Date:  2007-09-18       Impact factor: 2.991

3.  Synergistic anticancer activity of a novel oral chemotherapeutic agent containing trifluridine and tipiracil in combination with anti-PD-1 blockade in microsatellite stable-type murine colorectal cancer cells.

Authors:  Norihiko Suzuki; Hiroshi Tsukihara; Fumio Nakagawa; Takashi Kobunai; Teiji Takechi
Journal:  Am J Cancer Res       Date:  2017-10-01       Impact factor: 6.166

4.  Phase I study of TAS-102 treatment in Japanese patients with advanced solid tumours.

Authors:  T Doi; A Ohtsu; T Yoshino; N Boku; Y Onozawa; A Fukutomi; S Hironaka; W Koizumi; T Sasaki
Journal:  Br J Cancer       Date:  2012-06-26       Impact factor: 7.640

5.  2'-SCF3 uridine-a powerful label for probing structure and function of RNA by 19F NMR spectroscopy.

Authors:  Katja Fauster; Christoph Kreutz; Ronald Micura
Journal:  Angew Chem Int Ed Engl       Date:  2012-11-19       Impact factor: 15.336

6.  Simple and rapid enzymatic method for the synthesis of single-strand oligonucleotides containing trifluorothymidine.

Authors:  Norihiko Suzuki; Masakazu Fukushima
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2010-11       Impact factor: 1.381

7.  Repeated oral dosing of TAS-102 confers high trifluridine incorporation into DNA and sustained antitumor activity in mouse models.

Authors:  Nozomu Tanaka; Kazuki Sakamoto; Hiroyuki Okabe; Akio Fujioka; Keisuke Yamamura; Fumio Nakagawa; Hideki Nagase; Tatsushi Yokogawa; Kei Oguchi; Keiji Ishida; Akiko Osada; Hiromi Kazuno; Yukari Yamada; Kenichi Matsuo
Journal:  Oncol Rep       Date:  2014-09-17       Impact factor: 3.906

8.  Effect of a novel oral chemotherapeutic agent containing a combination of trifluridine, tipiracil and the novel triple angiokinase inhibitor nintedanib, on human colorectal cancer xenografts.

Authors:  Norihiko Suzuki; Fumio Nakagawa; Kazuaki Matsuoka; Teiji Takechi
Journal:  Oncol Rep       Date:  2016-10-27       Impact factor: 3.906

9.  Trifluridine/tipiracil increases survival rates in peritoneal dissemination mouse models of human colorectal and gastric cancer.

Authors:  Norihiko Suzuki; Fumio Nakagawa; Teiji Takechi
Journal:  Oncol Lett       Date:  2017-05-26       Impact factor: 2.967

Review 10.  Emerging combination therapies for metastatic colorectal cancer - impact of trifluridine/tipiracil.

Authors:  Jeevan M Puthiamadathil; Benjamin A Weinberg
Journal:  Cancer Manag Res       Date:  2017-10-03       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.